Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
about
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
description
scientific article published on 11 July 2019
@en
name
Canagliflozin and Cardiovascul ...... rdiovascular Prevention Groups
@en
type
label
Canagliflozin and Cardiovascul ...... rdiovascular Prevention Groups
@en
prefLabel
Canagliflozin and Cardiovascul ...... rdiovascular Prevention Groups
@en
P2093
P1433
P1476
Canagliflozin and Cardiovascul ...... rdiovascular Prevention Groups
@en
P2093
Adeera Levin
Barry M Brenner
Bernard Zinman
Carol Pollock
Christopher P Cannon
David C Wheeler
Dick de Zeeuw
George Bakris
George Capuano
Hiddo J L Heerspink
P304
P356
10.1161/CIRCULATIONAHA.119.042007
P577
2019-07-11T00:00:00Z